<p>Growth curves of BxPC-3 <b>(A)</b> and MIAPaCa-2 <b>(B)</b> tumors in mice treated with 0 MBq (black circles), 0.74 MBq (white squares), 1.85 MBq (black triangles), and 3.7 MBq (white diamonds) of <sup>90</sup>Y-TSP-A01. *<i>P</i> < 0.05, **<i>P</i> < 0.01 (vs. 0 MBq). Growth curves of BxPC-3 (<b>C</b>) and MIAPaCa-2 (<b>D</b>) tumors of mice treated with 0 Gy (black circles), 15 Gy (white squares), 30 Gy (black triangles), and 60 Gy (white diamonds) of X-rays. **<i>P</i> < 0.01 (vs. 0 Gy).</p
The low-affinity monoclonal antibody (MAb) chimeric 17-1A(c-17-1A) and the high-affinity MAb mouse 3...
<p>(A) Growth curves of LL/C tumors in non-irradiated (solid line, n = 5/each group) and irradiated ...
Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains poor. Therefore, the deve...
<div><p>Objective</p><p>Pancreatic cancer is an aggressive tumor and the prognosis remains poor. The...
Pancreatic cancer is an aggressive tumor and the prognosis remains poor. Therefore, development of m...
Objective Pancreatic cancer is an aggressive tumor and the prognosis remains poor. Therefore, de-vel...
<p>Tumor growth curve (<b>A</b>) and body weight (<b>B</b>) for mice treated with [<sup>90</sup>Y]12...
Y-TSP-A01 in pancreatic cancer mouse models.Y-TSP-A01 injection and histological analysis of tumors ...
Background: The aim of this study was to compare the therapeutic efficacy of two different activity ...
The poor prognosis of pancreatic cancer requires the development of more effective therapy. CD147 ex...
We radiolabeled the antibody with 125I by the chloramine-T method, and with 67Ga or 89Zr using defer...
The contribution of integrin α6β4 (α6β4) overexpression to the pancreaticcancer invasion and metasta...
Introduction: The purpose of this study was to compare the therapeutic efficacy and biodistribution ...
PURPOSE: To elucidate the therapeutic efficacy of alpha-radioimmunotherapy of ovarian cancer in mice...
PURPOSE: To elucidate the therapeutic efficacy of alpha-radioimmunotherapy of ovarian cancer in mice...
The low-affinity monoclonal antibody (MAb) chimeric 17-1A(c-17-1A) and the high-affinity MAb mouse 3...
<p>(A) Growth curves of LL/C tumors in non-irradiated (solid line, n = 5/each group) and irradiated ...
Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains poor. Therefore, the deve...
<div><p>Objective</p><p>Pancreatic cancer is an aggressive tumor and the prognosis remains poor. The...
Pancreatic cancer is an aggressive tumor and the prognosis remains poor. Therefore, development of m...
Objective Pancreatic cancer is an aggressive tumor and the prognosis remains poor. Therefore, de-vel...
<p>Tumor growth curve (<b>A</b>) and body weight (<b>B</b>) for mice treated with [<sup>90</sup>Y]12...
Y-TSP-A01 in pancreatic cancer mouse models.Y-TSP-A01 injection and histological analysis of tumors ...
Background: The aim of this study was to compare the therapeutic efficacy of two different activity ...
The poor prognosis of pancreatic cancer requires the development of more effective therapy. CD147 ex...
We radiolabeled the antibody with 125I by the chloramine-T method, and with 67Ga or 89Zr using defer...
The contribution of integrin α6β4 (α6β4) overexpression to the pancreaticcancer invasion and metasta...
Introduction: The purpose of this study was to compare the therapeutic efficacy and biodistribution ...
PURPOSE: To elucidate the therapeutic efficacy of alpha-radioimmunotherapy of ovarian cancer in mice...
PURPOSE: To elucidate the therapeutic efficacy of alpha-radioimmunotherapy of ovarian cancer in mice...
The low-affinity monoclonal antibody (MAb) chimeric 17-1A(c-17-1A) and the high-affinity MAb mouse 3...
<p>(A) Growth curves of LL/C tumors in non-irradiated (solid line, n = 5/each group) and irradiated ...
Small cell lung cancer (SCLC) is an aggressive tumor and prognosis remains poor. Therefore, the deve...